Skip to main content
PMC home page
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2007 May 1;6(3):399–406. doi: 10.1111/j.1582-4934.2002.tb00518.x

Oxidative stress in the pathogenesis of nonalcoholic fatty liver disease, in rats fed with a choline‐deficient diet

Claudia PMS Oliveira 1, L Carlos Da Costa Gayotto 2, Caroline Tatai 1, Bianca Ishimoto Della Bina 1, M Janiszewski 3, ES Lima 4, Dulcinéia SP Abdalla 4, FP Lopasso 1, FRM Laurindo 3, AA Laudanna 1
PMCID: PMC6740072  PMID: 12417056

Abstract

Background/Aim: The pathogenesis of Nonalcoholic Fatty Liver Disease remains largely unknown, but oxidative stress seems to be involved. The aim of this study was to evaluate the role of oxidative stress in experimental hepatic steatosis induced by a choline‐deficient diet. Methods: Fatty liver disease was induced in Wistar rats by a choline‐deficient diet. The animals were randomized into three groups: I (G1) and II (G2), n=6 each ‐ fed with a choline‐deficient diet for four and twelve weeks respectively; Group III (control‐G3; n=6) ‐ fed with a standard diet for twelve weeks. Samples of plasma and liver were submitted to biochemical, histological and oxidative stress analysis. Variables measured included serum levels of aminotransferases (AST, ALT), cholesterol and triglycerides. Oxidative stress was measured by lucigenin‐enhanced luminescence and the concentration of hydroperoxides (CE‐OOH‐cholesteryl ester) in the liver tissue. Results: We observed moderate macro‐ and microvesicular fatty change in periportal zones G1 and G2 as compared to controls (G3). In G2, fatty change was more severe. The inflammatory infiltrate was scanty and no fibrosis was seen in any group. There was a significant increase of AST and triglycerides in G1 and G2 as compared to control group G3. The lucigenin‐amplified luminescence (cpm/mg/min × 103) was significantly increased in G1 (1393±790) and G2 (7191±500) as compared to controls (513±170), p<0.05. The concentrations of CE‐OOH were higher in G1 (5.7±0.9 nmol/mg protein) as compared to control (2.6±0.7 nmol/mg protein), p<0.05. Conclusion: 1) Oxidative stress was found to be increased in experimental liver steatosis; 2) The production of reactive oxygen species was accentuated when liver steatosis was more severe; 3) The alterations produced by oxidative stress could be an important step in the pathogenesis of nonalcoholic fatty liver disease.

Keywords: non‐alcoholic fatty liver diseases, choline, oxidative stress, hydroperoxides, liver steatosis

References

  • 1. Powell E.E., Cooksley W.G., Hanson R., Searle J., Halliday J.W., Powell L.W., The natural histoty of nonalcoholic steatohepatitis: a follow‐up study of forty‐two patients for up to 21 years. Hepatology, 11: 74–80, 1990. [DOI] [PubMed] [Google Scholar]
  • 2. Lee R.G., Nonalcoholic steatohepatitis: a study of 49 patients. Hum. Pathol., 20: 594–598, 1989. [DOI] [PubMed] [Google Scholar]
  • 3. Ludwig J., Viggiano T.R., McGill D.B., Oh B.J., Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc., 55: 434–438, 1980. [PubMed] [Google Scholar]
  • 4. Ludwig J., McGill D.B., Lindor K.D., Metabolic liver diseases. Review: Nonalcoholic steatohepatitis. J. Gastroenterol. Hepatol., 12: 398–403, 1997. [DOI] [PubMed] [Google Scholar]
  • 5. Matteoni C.A., Younossi Z.M., Gramlich T.L. et al., Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology, 116: 1413–1419, 1999. [DOI] [PubMed] [Google Scholar]
  • 6. Yngve F.Y., Younossi Z.M., Marchesini G., McCullough A.J., Clinical features and natural history of nonalcoholic steatosis syndromes. Seminars in Liver Disease, 21: 17–26, 2001. [DOI] [PubMed] [Google Scholar]
  • 7. Chitturi S., Farrell G., Ethiopathogenesis of nonalcoholic steatohepatitis. Seminars in Liver Disease, 21: 27–41, 2001. [DOI] [PubMed] [Google Scholar]
  • 8. Day C.P., James O.E.W., Hepatic steatosis: innocent bystander or guilty party, Hepatology, 1463–1466, 1998. [DOI] [PubMed]
  • 9. Tilg H., Diehl A.M., Cytokines in alcoholic and nonalcoholic steatohepatitis. N. Engl. J. Med., 343: 1467–1476, 2000. [DOI] [PubMed] [Google Scholar]
  • 10. Wigg A.J., Roberts‐Thomson I.C., Dymock R.B., McCarthy P.J., Grose R.H., Cummins A.G., The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor α in the pathogenesis of nonalcoholic steatohepatitis. Gut, 48: 206–211, 2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Haines N.W., Baker A.L., Boyer J.L., Glagov S., Schneir H., Jaspan J., Fergunson D.J., Prognostic indicators of hepatic injury following jejunoileal bypass perfomed for refractory obesity: a prospective study. Hepatology, 1: 161–165, 1981. [DOI] [PubMed] [Google Scholar]
  • 12. Yang S.Q., Lin H.Z., Lane M.D., Clemens M., Dieh A.M., Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc. Natl. Acad. Sci. USA, 94: 2557–2562, 1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Yang S.Q., Zhu H., Li Y., Gabrielson K., Trush M.A., Diehl A.M., Mitochondrial adaptations to obesity‐related oxidant stress. Arch. Biochem. Biophysics, 378: 259–268, 2000. [DOI] [PubMed] [Google Scholar]
  • 14. Curzio M., Esterbauer H., Dianzani M.U., Chemotactic activity of hydroxyalkenals on rat neutrophils. Int. J. Tiss. Reac., 7: 137–142, 1985. [PubMed] [Google Scholar]
  • 15. Lee K.S., Buck M., Houglum K., Chojkier M., Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c‐myb expression. J. Clin. Invest., 96: 2461–2468, 1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Shronts E.P., Essential nature of choline with implications for total parenteral nutrition. J. Am. Diet. Assoc., 97: 639–646, 1997. [DOI] [PubMed] [Google Scholar]
  • 17. Zeisel S.H., Choline In: Shils M., Olson J.A., Shike M., eds. Modern nutrition in health and disease. 8th ed Philadelphia , Pa : Lea & Febiger, 1994, pp. 449–58. [Google Scholar]
  • 18. Teramoto K., Bowers J.L., Khettry U., Palombo J.D., Clouse M.E., A rat fatty liver transplant model. Transplantation, 55: 737–741, 1993. [DOI] [PubMed] [Google Scholar]
  • 19. Brandes R.P., Barton M., Philippens K.M.H., Schweitzer G., Mügge A., Endothelial‐derived superoxide anion in pig coronary arteries; evidence from lucigenin chemiluminescence and histochemical techniques. J. Physiol., 500: 331–342, 1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Yamamoto Y., Brodsky M.H., Baker J.C., Ames B.N., Detection and characterization of lipid hydroperoxides at picomole levels by high‐performance liquid chromatography. Analytical Chemistry, 160: 7–11, 1987. [DOI] [PubMed] [Google Scholar]
  • 21. Lettéron P., Fromenty B., Terris B., Degott C., Pessayre D., Acute and chronic steatosis lead to in vivo lipid proxidation in mice. J. Hepatol., 24: 200–208, 1996. [DOI] [PubMed] [Google Scholar]
  • 22. Li Y., Zhu H., Kuppusamy P., Roubaud V., Zweier J.I., Trush M.A., Validation of lucigenin (bis‐N‐methylacridinium) as a chemiluminescent probe for detecting superoxide anion radical production by enzimatic and cellular sources. J. Biol. Chem., 273:2015–2023, 1998. [DOI] [PubMed] [Google Scholar]
  • 23. Grattagliano I., Vendemiale G., Caraceni P., Domenicalli M., Nardo B., Cavallari A., Trevisani F. et al., Starvation impairs antioxidant defense in fatty livers of rats fed a choline‐deficient diet. J. Nutr., 130: 2131–2136, 2000. [DOI] [PubMed] [Google Scholar]
  • 24. Sreekumar R., Wiesner R.H., Nagomey D.M., Rosen C.B., Charlton M.R., Unique hepatic expression in NASH‐ candidates for a genetic basis of disease. Gastroenterology, 120: A‐119(580). [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES